Silversides Lecture Speaker: Dr. Michelle Mielke
Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention, Professor of Epidemiology, and Professor of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative diseases. One focus of her research is understanding the utility of blood-based biomarkers for implementation at the population-level for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and related dementias. Dr. Mielke is PI of several NIH-funded clinical- and epidemiological-based grants and has published over 400 manuscripts. She received the John R. Raymond Mentor Award from the Women Scholars Initiative and recently became a Fellow in the American Association for the Advancement of Science (AAAS), Section on Neuroscience.
Learning Objectives:
Discuss the current state of clinically available Alzheimer’s related blood-based biomarkers
Identify specific comorbidities that may affect the interpretation of blood-based Alzheimer’s disease biomarkers
Identify barriers to the implementation of blood-based biomarkers in primary care